Literature DB >> 11212258

Tobacco smoke-induced DNA damage and an early age of smoking initiation induce chromosome loss at 3p21 in lung cancer.

T Hirao1, H H Nelson, T D Ashok, J C Wain, E J Mark, D C Christiani, J K Wiencke, K T Kelsey.   

Abstract

The short arm of chromosome 3 is thought to harbor a novel oncogenic locus that is important in the genesis of lung cancer. The region at 3p21 is believed to contain a distinct locus that is sensitive to loss from the action of tobacco smoke carcinogens and has been reported to be specifically targeted for deletion in lung cancer. To investigate whether 3p21 alteration in lung cancer is associated with carcinogen exposure, PCR-based analysis was performed to detect loss of heterozygosity (LOH) on chromosome 3 at 3p21 in non-small cell lung carcinoma (NSCLC). We also measured instability at the BAT-26 locus, because the mismatch DNA repair gene, hMLH1, is found at 3p21. LOH at 3p21 was analyzed for association with the clinical features of NSCLC, p53 mutation status, polynuclear aromatic hydrocarbon-DNA adduct levels (measured using 32P-postlabeling) and carcinogen exposure information including cigarette smoking and asbestos exposure. Of 219 lung cancers, 150 cases (68.5%) were informative at the D3S1478 locus, and 44.2% of squamous cell carcinoma cases and 30.2% of adenocarcinoma cases showed 3p21 LOH. None of the cancers showed BAT-26 instability. The prevalence of 3p21 LOH was higher in both current and former smokers compared with never smokers and was higher in p53 mutated cases. Among squamous cell carcinoma cases, there was a strong association of increased 3p21 LOH with increasing polynuclear aromatic hydrocarbon-DNA adducts levels (P = 0.03), as well as an increased prevalence LOH with earlier age of smoking initiation (P = 0.02). Our results confirm that 3p21 LOH is strongly associated with measures of biologically effective dose of exposure to tobacco carcinogens. Our results also suggest that alterations of hMLH1 are not related to any of the reported associations, because there was no evidence of microsatellite instability. Finally, LOH in 3p21 may be an early molecular event in NSCLC, because it is significantly associated with a tendency to start smoking at a young age.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11212258

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  21 in total

1.  Modeling lung cancer risk in case-control studies using a new dose metric of smoking.

Authors:  Sally W Thurston; Geoffrey Liu; David P Miller; David C Christiani
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-10       Impact factor: 4.254

Review 2.  Biomarkers in bronchopulmonary cancer.

Authors:  María Martín Ureste; Regina Gironés Sarrió; Joaquín Montalar Salcedo
Journal:  Clin Transl Oncol       Date:  2010-02       Impact factor: 3.405

Review 3.  Systematic Review of Tobacco Use after Lung or Head/Neck Cancer Diagnosis: Results and Recommendations for Future Research.

Authors:  Jessica L Burris; Jamie L Studts; Antonio P DeRosa; Jamie S Ostroff
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-17       Impact factor: 4.254

4.  Potential of DNMT and its Epigenetic Regulation for Lung Cancer Therapy.

Authors:  Mingqing Tang; William Xu; Qizhao Wang; Weidong Xiao; Ruian Xu
Journal:  Curr Genomics       Date:  2009-08       Impact factor: 2.236

5.  Genetic and epigenetic tumor suppressor gene silencing are distinct molecular phenotypes driven by growth promoting mutations in nonsmall cell lung cancer.

Authors:  Carmen J Marsit; E Andres Houseman; Heather H Nelson; Karl T Kelsey
Journal:  J Cancer Epidemiol       Date:  2009-01-28

6.  Reduced Fhit protein expression in human malignant mesothelioma.

Authors:  Lea Pylkkänen; Henrik Wolff; Tuula Stjernvall; Aija Knuuttila; Sisko Anttila; Kirsti Husgafvel-Pursiainen
Journal:  Virchows Arch       Date:  2003-10-16       Impact factor: 4.064

7.  Cannabis use and risk of lung cancer: a case-control study.

Authors:  S Aldington; M Harwood; B Cox; M Weatherall; L Beckert; A Hansell; A Pritchard; G Robinson; R Beasley
Journal:  Eur Respir J       Date:  2008-02       Impact factor: 16.671

8.  BPDE induced lymphocytic chromosome 3p deletions may predict renal cell carcinoma risk.

Authors:  Yimin Zhu; Yohei Horikawa; Hushan Yang; Christopher G Wood; Tomonori Habuchi; Xifeng Wu
Journal:  J Urol       Date:  2008-04-23       Impact factor: 7.450

9.  Clinical significance of human leukocyte antigen loss and melanoma-associated antigen 4 expression in smokers of non-small cell lung cancer patients.

Authors:  Tetsuro Baba; Hironobu Shiota; Koji Kuroda; Yoshiki Shigematsu; Yoshinobu Ichiki; Hidetaka Uramoto; Takeshi Hanagiri; Fumihiro Tanaka
Journal:  Int J Clin Oncol       Date:  2012-11-03       Impact factor: 3.402

10.  Vitamin E intake and the lung cancer risk among female nonsmokers: a report from the Shanghai Women's Health Study.

Authors:  Qi-Jun Wu; Yong-Bing Xiang; Gong Yang; Hong-Lan Li; Qing Lan; Yu-Tang Gao; Wei Zheng; Xiao-Ou Shu; Jay H Fowke
Journal:  Int J Cancer       Date:  2014-06-19       Impact factor: 7.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.